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Abstract. Shortages of essential supplies used to prevent, diagnose, and treatCOVID-19 have been aglobal concern,
and price speculation and hikes may have negatively influenced access. This study identifies variability in prices of
products acquired through government-driven contracts in Ecuador during the early pandemic response, when the
highest mortality rates were registered in a single day. Data were obtained from the National Public Procurement Service
(SERCOP) database between March 1 and July 31, 2020. A statistical descriptive analysis was conducted to extract
relevant measures for commonly purchased products, medical devices, pharmaceutical drugs, and other goods. Among
the most frequently purchased products, the greatest amounts were spent on face masks (US$4.5 million), acetamino-
phen (US$2.2million), and reverse transcriptasequantitative polymerase chain reaction assay kits (US$1.8million). Prices
varied greatly, depending on each individual contract and on the number of units purchased; some were exceptionally
higher than their market value. Compared with 2019, the mean price of medical examination gloves increased up to
1,307%, acetaminophen 500 mg pills, up to 796%, and oxygen flasks, 30.8%. In a context of budgetary constraints that
actually required an effective use of available funds, speculative price hikesmay have limited patient access to health care
and the protection of the general population and health care workers. COVID-19 vaccine allocations to privileged indi-
viduals have also been widely reported. Price caps and other forms of regulation, as well as greater scrutiny and
transparency of government-driven purchases, and investment in local production, are warranted in Ecuador for im-
proved infectious disease prevention.
INTRODUCTION
Shortages of essential supplies used to prevent, diagnose,
and treatCOVID-19 have been documented around theworld,
with the pandemic exacerbating the impact of systemic
weaknesses on availability in places with high transmission
rates.1 Lack of medical devices such as mechanical ventila-
tors, reverse transcriptase quantitative polymerase chain re-
action (RT-qPCR) test kits, and a full range of personal
protection equipment (PPE) for health care workers to safely
comply with clinical duty has not been the only cause for
concern; limited access to basic food supplies may increase
exposure and vulnerability to the disease.2
Breaches of anticorruption standards, including surcharges,
speculation, collusion, cutting corners in procurement process-
es, andevenpoliticians takingadvantageof thecrisis to increase
their private benefits, have been recorded in various countries
during the COVID-19 pandemic.3 Government transparency in
decision-making has been described as a major problem in
response efforts worldwide,4 together with weak regulations
and accountability mechanisms and low wages in the heath
sector.5 In countries such as the United Kingdom, a National
Health Service official was found selling PPE on the side, and
theU.S. administration paid extraordinary prices to third-party
vendors.6
Ecuador is a South American country of 17 million people,
which was severely hit early in the pandemic, registeringmore
than 40,000 deaths in 2020, one of the highest rates per capita
in the world. Although the government declared a health
emergency in March followed by a national lockdown, social
protection measures and health system resources have been
limited. Vulnerable populations have also relied, for example,
on food kits from the World Food Program7 and provisionally
lower-priced food and drug outlets supported by the peasant
movement (Movimiento Social Campesino, FECAOL, in
Spanish).8,9
Most medical equipment, devices, and medicines are im-
ported into Ecuador, and the public health sector’s resource
allocation has forced populations to pay out of pocket for
medication in the past, placing those who cannot pay at
greater risk.10 As the country’s health system became over-
stretched to the point of collapse in Guayas, the first COVID-
19hotspot,11,12major corruption scandals emerged in relation
to the procurement of medical devices such as face masks or
human remains pouches (HRPs), commonly known as body
bags.13 Even though the law requires civil society organiza-
tions’ participation in Emergency Operations Committee
meetings, they have not been present during the sessions
convened for the pandemic response, which has limited
transparency in decision-making.14 In addition, as Ecuador
was seeing a steady rise in the number of confirmed cases
early in the pandemic, its diagnostic capacity did not increase
to meet demands.15
Ecuador mandated face masks on April 7, 2020, for the
general population,16 but these were not freely distributed by
the government nor was a price cap established. In practice,
this implied that only people with enough means could pur-
chase them to remain protected.17 Similarly, in countries with
limited resources, those who can afford expensive private
testing may presumably be at an advantage over those who
cannot. With only 14% of medicines being produced locally,
and 86% of this revenue going to a single company,18 market
prices are not necessarily competitive. It has been reported
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that at least 202 public contracts signed during the pandemic
response have irregularities; a majority of them involve the
purchase of medical supplies, masks, suits, antibacterial gel,
PCR tests, medicines, food kits, and other products and ser-
vices.19 The comptroller general of Ecuador found that food
kits were purchased by public institutions for distribution
among vulnerable groups across the country at amuch higher
cost than regular store prices.20,21 Furthermore, tocilizumab
vials donated by a pharmaceutical company to the govern-
ment were sold on the black market for at least 5 and up to 10
times their market price in April 2020.22 Finally, oxygen
shortages and exceedingly high prices were also reported by
the media in early April of the same year.23
This study aims to compare variability in prices of products
acquired through public contracts in Ecuador for use in clinical
settings or as protection for the general population in re-
sponse to the COVID-19 pandemic.
METHODS
Study design. This is an observational descriptive study of
the publicly available data on government-driven purchases
for the public health system in Ecuador from January 1, 2020
to July 31, 2020.
Setting. The study was conducted in Ecuador, a country
located in South America, with an estimated population of
17.68 million. The National Public Procurement Service
(SERCOP) is in charge of promoting citizen participation, in-
creasing access to and use of public information by the pop-
ulation, increasing transparency, and fighting fraud and
corruption that could arise from bad practices in public pro-
curement. Our study quantifies differences in prices of com-
monly purchased devices, medicines, and supplies in public
contracts registered in SERCOP that have been identified as
relating to the COVID-19 pandemic.
Variables. Considering the Uniform Resource Locator
(URL) of each contracting process as input, the following
sections were identified: description, dates, products, quali-
fication parameters, invitations, files, and questions from
suppliers. Each section was extracted through scraping
according to its equivalent identification in html and was
stored in an unrelated database. The variables analyzed were
as follows: governmental institution responsible for the pur-
chase process (Ministry, Central Government, Decentralized
Autonomous Governments), location where the contract was
based (Municipality and Province), type of product or service,
unit price, and type of contract (direct contract or public
auction).
Data sources. Data were obtained from the publicly avail-
able database from SERCOP. Data on government-driven
purchaseprocessesbetweenMarch1andJuly 31, 2020,were
extracted using Selenium with Python. Using fuzzy matching
and regular expressions, we identified the most frequent
products in the bids and contracts. The source code of python
script is available in the following link: https://github.com/
torresyeferson/DattaMinigCorruption/blob/main/Scraping.py
Statistical method. A statistical descriptive analysis was
conducted to extract relevant measures for each product and
determine variability across all items. Tableau software was
used for visualization and analysis. A descriptive statistical
analysis was performed to describe means, trends and per-
centage changes.
RESULTS
Data by institution. The highest spenders during the peak
of the pandemic in 2020 were the Guayaquil Municipal Gov-
ernment (US$19 million) and the Guayas Provincial Govern-
ment (US$5 million), followed by the Ministry of Public Health
(US$18 million). Hospitals that spent the largest sums were
also located in Guayaquil—Sagrado Corazon de Jesus and
Abel Gilbert Ponton—which spent approximately US$5 mil-
lion each (Table 1).
As a reference, Ecuador has 168 public hospitals; its 19
highest spenders used 1.4% of Ecuador’s 2018 total public
health budget (US$2.665 million) in only 3 months, between
March 1 and May 31, 2020.24
Data by product or service. The most frequently pur-
chased products in public contracts were medical devices
(ventilators), laboratory supplies (RT-qPCR assay kits), all
types of facial masks (including N95 respirators, surgical
masks, and face masks), medicines (acetaminophen, piper-
acillin, hydroxychloroquine), disinfectant (quaternary ammo-
nium), HRPs, and food kits.
Data by prices.Prices varied by contract and depended on
the number of units purchased. Distribution of prices for all
main products are included in Figure 1. During the study pe-
riod, prices were analyzed by item, institution, and month,
ranging from individual products as cheap as US$0.03 (acet-
aminophen 500 mg pills) to US$140,000 (mechanical venti-
lators). A total of US$4.5 million was spent on all types of
masks (including N95 respirators, surgical masks, and face
masks), ranging from US$0.50 to US$90 per unit. The gov-
ernment spent at least US$2.2million on acetaminophen, with
prices ranging from US$0.04 per 500-mg pill to US$2.65 per
oral suspension bottle (different sizes). In terms of diagnostic
supplies, at least US$1.8 million were spent on RT-qPCR
essay kits. The lowest price for an individual primer was
US$18 (per reaction) and the highest wasUS$85 per reaction
when including the extraction kit. The price of an individual
HRP reached exceptional high values per unit. For instance,
the Ecuadorian Institute of Social Security (IESS) bought
4,000 units at US$148.5 per HRP, a value 493% higher than
the market price of US$25.13 Prices of individual items per
unit can be found in the link shared in the Availability of Data
section.
In another exceptional purchase, the National Secretariat
for Risk Management acquired 7,000 food kits for vulnerable
families, at US$150.82 per hamper. The Comptroller General
of Ecuador has subsequently established that the market
value of each food kit is US$95.16, one of the reasons being
that only eight of the 18 products are taxable, but the vendor
had includeda tax value for all items.21 Furthermore, the report
indicates prices were also inflated.
Data by dates. The prices of food kits andmedical supplies
such as face masks experienced sharp increases during the
first few months of the pandemic (Figure 2). Although the pri-
ces of face masks oscillated greatly since at least 2019, the
increase in April and May 2020 is evident (Figure 3).
Most of the increase was on products that were highly
neededduring the health emergency causedby theCOVID-19
pandemic. Compared with the previous year, medical exam
gloves increased by 1,307%, acetaminophen 500-mg pills by
796%, and oxygen flasks (different sizes) by 30.8% in the
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corresponding month during which data were available
(Table 2).
DISCUSSION
The data in this study show great variability of prices and
extreme price hikes in government-driven purchases related
to the COVID-19 response in Ecuador—in particular, during
the peak of the pandemic in the country’s initial hotspot of
Guayas. Although it is true that greater worldwide demand
for medical equipment and supplies drove price increases
in both high-income and low- and middle-income countries,
government-based contracts in Ecuador diverted from mar-
ket prices. Furthermore, the national and local governments,
public hospitals, and the National Secretariat for Risk Man-
agement do not appear to have coordinated bulk negotiations
TABLE 1
Expenditures of local hospitals (March 1–May 31, 2020)
Hospital
March April May Total
% Of total(in US$) (in US$) (in US$) (in US$)
Hospital Sagrado Corazon de Jesus 2,845,134 2,519,196 – 5,364,330 14%
Hospital Abel Gilbert Ponton 4,581,303 249,207 – 4,830,510 13%
Hospital Quito-Sur 2,799,047 – – 2,799,047 7%
Hospital Martin Icaza 1,555,057 705,002 153,566 2,413,625 6%
Hospital General de Machala 1,669,934 391,820 – 2,061,754 5%
Hospital General Enrique Garcés 1,965,252 – – 1,965,252 5%
Hospital de Especialidades Carlos
Andrade Marin
1,826,454 58,500 – 1,884,954 5%
Hospital del Niño 1,840,205 24,754 – 1,864,959 5%
Hospital General Monte Sinaı́ 1,421,120 426,689 – 1,847,809 5%
Hospital General de Milagro 1,529,479 188,787 – 1,718,266 5%
Hospital General Guasmo Sur 1,666,462 – – 1,666,462 4%
Hospital de Especialidades Eugenio
Espejo
1,600,469 – – 1,600,469 4%
Hospital de Especialidades Fuerzas
Armadas No. 1
557,525 682,018 117,467 1,357,010 4%
Hospital General Marco Vinicio Iza 588,664 656,694 – 1,245,358 3%
Hospital General de Manta 1,196,829 45,298 – 1,242,127 3%
Hospital de Especialidades Jose
Carrasco Arteaga
989,979 220,553 – 1,210,532 3%
Hospital Vicente Corral Moscoso 979,148 45,269 – 1,024,417 3%
Hospital Rodrı́guez Zambrano 963,248 – – 963,248 3%
Hospital General de Ambato 848,625 – – 848,625 2%
Total 31,423,934 6,213,787 271,033 37,908,754 100%
FIGURE 1. Price distributionof basic supplies related to theCOVID-19 response in Ecuador (March1–July 31, 2020). The plot depicts variations in
price by item compared with the median/mean price, using as reference outliers in distribution in a logarithmic scale. Dots outside bars and boxes
represent extreme and atypical values.
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to ensure better prices. In addition, exceptional purchases of
ammonium quaternary and hydroxychloroquine by the Ecua-
dorian government show that decisions were not necessarily
based on need or the best available evidence.25 As a conse-
quence, government expenditures appear to have been costly
and also wasteful.
Irrespectiveof limits indiagnostic capacity,whicharea reality
in Ecuador, high prices of RT-qPCR primers and extraction kits
in government-driven purchases may have had a negative im-
pact on the number of tests that theMinistry of Health was able
to afford.15 Accordingly, an increase in the public health budget
probably would not have led to greater access to testing
through added purchases but instead to further speculation
and price hikes. Thismay help to explain the high price caps set
by thegovernment:US$80per publicly fundedandUS$120per
privately paid RT-qPCR assay. Unsurprisingly, there was se-
vere undertesting in the country during the study period, with
RT-qPCR positivity rates (total confirmed cases as a share of
the total number of people tested) between 48% on May 1,
202026 and 42% on July 31, 2020.27
Although the current analysis concerns only government-
driven purchases, private demand for medical supplies and
medicines in a country reliant on imports and with highly
concentrated local production of medicines may have also
influenced price increases. However, there is no evidence that
the government was trying to keep prices down through
control mechanisms or at least greater scrutiny and ac-
countability of public purchases. Media reports on corruption
in government-driven purchases pointed toward contracts
remaining largely unmonitored as the health emergency
TABLE 2
Comparison of mean prices between January 1, 2019 and May 30, 2020*
Month 2019 2020 % Increase
Medical exam and sterile gloves (100
units)
Jan $0.03 $0.07 144%
April $0.19 $2.67 1,307%
May $1.66 $2.81 69%
Acetaminophen (500-mg pill) Jan $0.002 $0.014 796%
April $0.002 $0.004 166%
Oxygen (flasks, different sizes) April $2.82 $3.69 30.8%
*Values are shown only for the month in which purchases occurred in the database. Prices of individual items per unit can be found in the link shared in the Availability of Data section.
FIGURE 2. Price distribution of face masks and food kits in Ecuador by month (August 1, 2019–May 31, 2020). We selected these two items for
comparison because contractsmost frequently included them; data for other itemswere not available for the 2 years. This figure appears in color at
www.ajtmh.org.
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unfolded,28,29 and investing in local production was not a high
priority in the government agenda.
Speculative price hikes amid constraints in public spending
may have limited patient access to diagnosis and treatment of
COVID-19, and protection of both the general population and
health workers in clinical settings. Prices of PPE and medi-
cines, including hydroxychloroquine (antimalarial medication
that was briefly suggested for COVID-19 treatment) experi-
enced increases in several countries.30 Lack of PPE may help
to explain why, early in the pandemic (February 2–April 18,
2020), themost impacted occupational sector in Ecuador was
health care (19% of total COVID-19 confirmed cases).31 Al-
though moderate increases in prices have not been found to
negatively influencepurchaseof PPE, extreme increases such
as 1,307% on the price of medical gloves may have had a
limiting effect.
In countries such as Brazil, oxygen shortages and price
speculation led to the death of vulnerable patients who were
not able to procure cylinders that hadbeen reserved for sale to
the wealthy.32 Similarly, the city of Guayaquil reported short-
ages and prices up to US$50 for the refill of an oxygen cylin-
der23 in early April, when a record number of people died.
Although the excessive cost of food kits illustrates wide-
spread speculation in COVID-19 related government-driven
contracts, it is important to note that nutritional status may
have been affected by the number of people who could ac-
tually receive this type of aid. Moreover, under such circum-
stances, requests for people to stay at home or quarantine
were difficult to meet when they had to acquire their means of
subsistence through informal work or personally procure
foodstuffs, further undermining proper prevention and treat-
ment. Direct purchases by the government from farming
associations that were already helping in the response could
have helped reach more people, together with keeping the
economy moving, with the funds that had been allocated for
emergency food procurement.8,9
Finally, information on COVID-19 vaccine vials is not avail-
able through SERCOP or other data sources, and the prices
paid for them are unknown at the time of this publication. Un-
planned, unethical allocationofdosesprivilegingpublicofficials
and their spouses, journalists, and businesspeople has been
widely reported,33 making it even more relevant than before to
correct obscure practices in the use of public health resources.
Study limitations. This study has limitations. First, data
collection and analysis focused on the most frequently iden-
tified products in public contracts citing COVID-19.We do not
knowwhat the case is in other, including essential, supplies or
equipment. Second, we do not have data on patient access to
health care, such as diagnosis and treatment of COVID-19, so
we cannot provide conclusions on the impact of price varia-
tion. Third, we do not know the factors that may have influ-
enced product pricing, such as global increase in the cost of
materials and transportation due to disruptions in supply
chains. Nevertheless, the study brings to the fore public pur-
chase practices that may have a detrimental effect on health
outcomes.
CONCLUSION
The COVID-19 pandemic has exposed flaws in health sys-
tem governance around the world, highlighting the potential
for price speculation and unjustified hikes in prices to un-
dermine the effectiveness of country responses. At the be-
ginning of the pandemic, Ecuador suffered one of the most
FIGURE 3. Monthly price of facemasks in public contracts (there was no information for January andMarch 2019). This figure appears in color at
www.ajtmh.org.
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aggressive outbreaks of COVID-19 worldwide, and many
questions have remained unanswered regarding the ex-
tremely high spike in confirmed cases and excessive deaths in
provinces such as Guayas. An unfulfilled need for continuous
access to facemasks for thegeneral population, aswell as food
supplies, may have played a role in the increased transmission
in the country. Supplies allocation during the COVID-19 re-
sponse depended on budgetary constraints due to Ecuador’s
ongoing financial crisis andconsequently required effectiveuse
of available funds. Furthermore, additional dependanceonout-
of-pocket payments warranted price caps and other forms of
regulation, as well as greater scrutiny of public purchases.
Improvements in the health system and pandemic pre-
paredness efforts should focus on ensuring adequate in-
vestment of public resources and planning for availability of
supplies for the prevention of infectious diseases. Anticipating
bulk purchases across hospitals, at the least, and across other
institutions and sectors, should be prioritized to help guar-
antee affordable prices not just within the public health sector
but also for patientswhomay be forced to pay out of pocket or
use their private insurance. Especially in the case of an in-
expensive but apparently highly effective measure such as
mandatory or voluntary mask wearing, basic price controls
may induce better compliance with self-care activities.
Investing in local production of medical supplies and com-
plementary but essential resources such as food should also
be considered.
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